FDC
|
The Current P/B Ratio of FDC is 2.68.
| Share Price | ₹376.0 | Feb 13,2026 |
| Market Cap | ₹6,120.5 Cr | |
| Book Value | ₹2,281.1 Cr | Mar2025 - Consolidated Results |
| Price/Book | 2.68x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of FDC
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹6,120.5 Cr] as on Feb 13,2026
(/) Book Value [ ₹2,281.1 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 2.68x ]
Thus, for FDC , the investors are currently willing to pay '2.68 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of FDC !
The chart below summarizes the trend in P/B Ratio of FDC over the last five years.
Historical PB (Price/Book ) ratio chart of FDC
PB Ratio Performance Analysis for FDC
- FDC 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.65x.
- FDC 's operated at median p/b ratio of 2.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/b ratio peaked in Mar2024 at 3.3x.
- FDC 's p/b ratio hit its five-year low in Mar2023 of 2.15x.
How does FDC 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| FDC | 2,281.08 | 2.68 | 6,120.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.64 | 407,431.0 |
| DIVIS LABORATORIES LTD | 14,969.00 | 10.94 | 163,772.0 |
| CIPLA LTD | 31,079.30 | 3.46 | 107,503.0 |
| TORRENT PHARMACEUTICALS LTD | 7,590.69 | 18.16 | 137,884.0 |
| DR REDDYS LABORATORIES LTD | 33,404.90 | 3.17 | 105,798.0 |
| MANKIND PHARMA LTD | 14,288.70 | 5.95 | 85,050.2 |
| ZYDUS LIFESCIENCES LTD | 23,953.10 | 3.80 | 91,049.1 |
| LUPIN LTD | 17,119.50 | 5.87 | 100,496.0 |
| AUROBINDO PHARMA LTD | 32,653.30 | 2.04 | 66,705.1 |
| ABBOTT INDIA LTD | 4,204.27 | 13.38 | 56,246.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs FDC 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.04x |
| Max industry PB | 18.16x |
| Median industry PB | 5.64x |
| Average industry PB | 6.83x |
You may also like the below Video Courses